<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131-pharmaceuticals-13-00096">
 <label>131.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dijkman</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Jebbink</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Deijs</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Milewska</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pyrc</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Buelow</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Van der Bijl</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Van der Hoek</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63</article-title>
  <source>J. Gen. Virol.</source>
  <year>2012</year>
  <volume>93</volume>
  <fpage>1924</fpage>
  <lpage>1929</lpage>
  <pub-id pub-id-type="doi">10.1099/vir.0.043919-0</pub-id>
  <?supplied-pmid 22718567?>
  <pub-id pub-id-type="pmid">22718567</pub-id>
 </element-citation>
</ref>
